X5V-73931-94602 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-26
Dose 2 — Pfizer-BioNTech
2021-01-27
Registered in v-safe
2021-01-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache · Be unable to do your normal daily activities

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-02
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-04
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-27
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-27
Survey response — 6 months, dose 2
MedDRA: Anxiety — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Anxiety

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-27
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-05
Call 1 — Left Voicemail
2022-03-21
Dose 3 — Pfizer-BioNTech
2022-04-21
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-09-21
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-03-22
Survey response — 12 months, dose 3
MedDRA: Cholelithiasis — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-03-22
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2023-03-23
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-03-23
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech
2	2021-01-26	Pfizer-BioNTech
3	2022-03-21	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-07-27	Successful 2023-03-23	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-03-22	Successful 2023-03-23	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 9 — 6 months, dose 2

2021-07-27

Symptoms: Anxiety

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anxiety	✓	·	✓
SD	Cholelithiasis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release